Хайлтын үр дүнгүүд - Mark Thalgott
- 3-н 1 - 3 үр дүнгүүдийг харуулж байна
-
1
One-Stop-Shop Whole-Body <sup>68</sup>Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer -н Mark Thalgott, Charlotte Düwel, Isabel Rauscher, Matthias Heck, Bernhard Haller, Andrei Gafita, Jürgen E. Gschwend, Markus Schwaiger, Tobias Maurer, Matthias Eiber
Хэвлэсэн 2018Artigo -
2
Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer -н Mark Thalgott, Thomas Horn, Matthias Heck, Tobias Maurer, Matthias Eiber, Margitta Retz, Michael Autenrieth, Kathleen Herkommer, Bernd J. Krause, Jürgen E. Gschwend, Uwe Treiber, Hubert Kübler
Хэвлэсэн 2014Artigo -
3
Chromogranin A and neurone‐specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration‐resistant prostate cancer undergoing abiraterone... -н Matthias Heck, Markus Thaler, Sebastian C. Schmid, Anna‐Katharina Seitz, Robert Tauber, Hubert Kübler, Tobias Maurer, Mark Thalgott, Georgios Hatzichristodoulou, Michael Höppner, Roman Nawroth, Peter B. Luppa, Jürgen E. Gschwend, Margitta Retz
Хэвлэсэн 2016Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Cancer
Internal medicine
Medicine
Oncology
Prostate cancer
Chemotherapy
Urology
Androgen
Biology
Blockade
Chromogranin A
Concordance
Docetaxel
Enolase
Gastroenterology
Hematology
Hormone
Immunohistochemistry
Lymph node
Nomogram
Nuclear medicine
Paleontology
Progression-free survival
Proportional hazards model
Prostate
Prostate-specific antigen
Prostatectomy
Radiology
Receiver operating characteristic
Receptor